跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Naabak - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Naabak
Approved
STANDARD
Naabak
Excelvision
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
af7803a7464b165e
Company
Excelvision
Type
Standard
Approval Details
Approval Id
af7803a7464b165e
Drug Approval Philippines Name
Naabak
Product Name
Naabak
Registration Number
DR-XY35545
Brand Name
Naabak
Generic Name
N-Acetyl Aspartyl Glutamic Acid Sodium Salt
Dosage Form
Ophthalmic Solution (Eye Drops)
Dosage Strength
49mg/mL
Manufacturer
Excelvision
Importer
STADA Philippines Inc.
Distributor
STADA Philippines Inc.
Company Detail Path
/organization/excelvision
Issuance Date
16 November 2023
Expiry Date
13 October 2029
Pharmacologic Category
Anti-Allergy
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
af7803a7464b165e
Type
Standard
Back to Philippines FDA Approvals